Publications
Amplify
An RNA-Based Vaccine Platform for Use against Mycobacterium tuberculosis – Vaccines 2023
Click here to view article
Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine. — EBioMedicine
Click here to view article
A replicon RNA vaccine induces durable protective immunity from SARS-CoV-2 in nonhuman primates after neutralizing antibodies have waned — BiorXiv
Click here to view article
Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge. — EBioMedicine
Click here to view article
Intramuscular delivery of formulated RNA encoding six linked nanobodies is highly protective for exposures to three Botulinum neurotoxin serotypes. — Nature Scientific Reports
Click here to view article
Activate
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Access
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.